4 ms·
You're cherry picking a single vaccine and failing to understand how the "D" part of R&D works. The vast majority of drug development expense comes from large s
by nradov 2y ago
You're cherry picking a single vaccine and failing to understand how the "D" part of R&D works. The vast majority of drug development expense comes from large scale phase-3 human clinical trials. Those now cost ~$1B each (necessary to establish safety and effectiveness) and many fail. Outside of rare circumstances like a global pandemic there is little political appetite anywhere in the world for widespread public funding of phase-3 trials. It's just never going to happen, and even if it did there's no evidence that government bureaucrats would make good decisions about which trials to fund.
- like_any_other 2y agoAre the 9 out of 10 big pharma companies who spend more on marketing than on R&D also "cherry picked"?